No Benefit From Platelet Transfusion for Gastrointestinal Bleeding in Patients Taking Antiplatelet Agents

Clinical Gastroenterology and Hepatology

Volumn 15, Issue 1, 2017, Pages 46-52

  Zakko, Liam ^a,b   Rustagi, Tarun ^a,b   Douglas, Maura ^b   Laine, Loren ^b,c  

^a MAYO CLINIC   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Aspirin; Clopidogrel; Stomach; Thienopyridines

Indexed keywords

ANTITHROMBOCYTIC AGENT; HEMOGLOBIN;

AGE; AGED; ARTICLE; BLOOD PRESSURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEART RATE; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEX; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; ADULT; MIDDLE AGED; SECONDARY PREVENTION; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET TRANSFUSION; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85006444825     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2016.07.017     Document Type: Article

References (25)

1. 1 Antithrombotic Trialists (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet 373 (2009), 1849–1860.
2. 2 McQuaid, K.R., Laine, L., Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med 119 (2006), 624–638.
3. 3 Yusuf, S., Zhao, F., Mehta, S.R., et al. Clopidogrel in Unstable Angina to Prevent Recurrent Events trial investigators: effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001), 494–502.
4. 4 The ACTIVE investigators, Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 360 (2009), 2066–2078.
5. 5 The SPS3 investigators, Effects of clopidogrel added to aspirin in patients with lacunar stroke. N Engl J Med 367 (2012), 817–825.
6. 6 Acosta, R.D., Abraham, N.S., Chandrasekhara, V., et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc 83 (2016), 3–16.
7. 7 Strode, R., How do I transfuse platelets to reverse anti-platelet drug effect?. Transfusion 52 (2012), 695–701.
8. 8 Razzaghi, A., Barkun, A.N., Platelet transfusion threshold in patients with upper gastrointestinal bleeding: a systematic review. J Clin Gastroenterol 46 (2012), 482–486.
9. 9 Victor, N., Umakanthan, J., Gandhi, A., et al. Role of platelet transfusion in gastrointestinal bleeding in patients on anti-platelet therapy. Crit Care Med, 42, 2014, A1461.
10. 10 Charlson, M.E., Pompei, P., Ales, K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987), 373–383.
11. 11 Laine, L., Spiegel, B., Rostom, A., et al. Methodology for randomized trials of patients with nonvariceal upper gastrointestinal bleeding: recommendations from an international consensus conference. Am J Gastroenterol 105 (2010), 540–550.
12. 12 Rockall, T.A., Logan, R.F.A., Devlin, H.B., et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 38 (1996), 316–321.
13. 13 Sung, J.J.Y., Tsoi, K.K.F., Ma, T.K.W., Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol 105 (2010), 84–89.
14. 14 Chan, F.K.L., Chung, S.C.S., Suen, B.Y., et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 344 (2001), 967–973.
15. 15 Sung, J.J.Y., Lau, J.W.Y., Ching, J.Y.L., et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med 152 (2010), 1–9.
16. 16 Lai, K.C., Chu, K.M., Hui, W.M., et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. Clin Gastroenterol Hepatol 4 (2006), 860–865.
17. 17 Chan, F.K.L., Ching, J.Y.L., Hug, L.C.T., et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 352 (2005), 238–244.
18. 18 Wehbeh, A., Tamim, H.M., Abu Daya, H., Aspirin has a protective effect against adverse outcomes in patients with non-variceal upper gastrointestinal bleeding. Dig Dis Sci 60 (2015), 2077–2087.
19. 19 Sahler, J., Grimshaw, K., Spinelli, S.L., et al. Platelet storage and transfusions: new concerns associated with an old therapy. Drug Discov Today Dis Mech 8 (2011), e9–e14.
20. 20 Villanueva, C., Colomo, A., Bosch, A., et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 368 (2013), 11–21.
21. 21 Spiess, B.D., Royston, D., Levy, J.H., et al. Platelet transfusion during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 44 (2004), 1143–1148.
22. 22 Kaufman, R.M., Djulbegovic, B., Gernsheimer, T., et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med 162 (2015), 205–213.
23. 23 Laine, L., Jensen, D.M., ACG practice guidelines: management of patients with ulcer bleeding. Am J Gastroenterol 107 (2012), 345–360.
24. 24 Anderson, M.A., Ben-Menachem, T., Gan, S.I., et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc 70 (2009), 1060–1070.
25. 25 Taha, A.S., Kelly, C., McCloskey, C., et al. Upper gastrointestinal bleeding in hospital inpatients: the role of antithrombotic drugs. Postgrad Med J 90 (2014), 429–433.